Insilico Medicine, Inc., a Baltimore-based next-generation artificial intelligence company specializing in the application of deep learning for drug discovery, announces that Juvenescence.AI, its joint venture with Juvenescence Limited, has licensed its first compound family for clinical development.
- Innarah launches new rechargeable electronic skin care device which works on Radio Frequency July 20, 2018
- Reeling from the news? Train your brain to feel better with these 4 techniques July 20, 2018
- | Health July 20, 2018
- Innarah launches new rechargeable electronic skin care device which works on Radio Frequency July 18, 2018
- Electric scooters on collision course with pedestrians and lawmakers July 18, 2018
- | Health July 18, 2018